BMCM
GSK icon

Burns Matteson Capital Management’s GSK GSK Stock Holding History

Burns Matteson Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Sell
9,423
-335
-3% -$17.7K 0.15% 114
2026
Q1 		$539K Buy
+9,758
New +$529K 0.2% 103

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Burns Matteson Capital Management's GSK Position: Q2 2026 in Review

Burns Matteson Capital Management reduced its GSK (GSK) stake by 3.4% in Q2 2026, selling an estimated $17.7K and leaving 9,423 shares worth $494K. The position accounts for 0.15% of the portfolio, ranked #114.

Burns Matteson Capital Management first reported a position in GSK in Q1 2026 and has held it in 2 quarters since. The position peaked at $539K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Burns Matteson Capital Management held 9,423 shares of GSK worth $494K as of Q2 2026.
  • Burns Matteson Capital Management sold 335 GSK shares in Q2 2026, an estimated $17.7K.
  • GSK made up 0.15% of Burns Matteson Capital Management's portfolio in Q2 2026, its #114 holding.
  • Burns Matteson Capital Management first reported a position in GSK in Q1 2026 and has held it in 2 quarters since.
  • Burns Matteson Capital Management's GSK position peaked at $539K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Burns Matteson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.